NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 4, 2026 Bullish $5.54 V 1
Mar 3, 2026 $4.88 -3.31% $5.31 X 91.96% 0
Mar 3, 2026 $4.95 -2.07% $5.31 X 93.14% 0
Mar 3, 2026 $5.10 +0.99% $5.31 V 96.05% 1
Mar 2, 2026 $4.77 -3.31% $5.05 X 94.39% 0
Mar 2, 2026 $4.83 -2.07% $5.05 X 95.60% 0
Mar 2, 2026 $5.08 +3.04% $5.05 V 99.41% 4
Mar 2, 2026 Bullish $5.05 V 1
Feb 27, 2026 $4.76 -3.27% $4.93 X 96.54% 0
Feb 27, 2026 $4.82 -2.04% $4.93 X 97.76% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE